Helping the Mental Health Industry Generate Tangible Growth. KRFI Global Health Initiative 2030 Conference brings market intelligence and business connections for the Private Public Sector Partnership for the Mental Health and current Endemic Opioid Use and Substance Use (OUD/SUD) Disorder into US FDA approved therapeutics by bringing a private-public sector Partnership as an ibogaine and Psychedelic as new natural medicine industry growth.

We help companies expand their clinical impact, and diagnostic influence, make data-driven decisions through our industry intelligence, and link up with natural products psychedelic manufacturing pharmaceutical professionals to exchange knowledge and engage in quality networking.

At the core of KRFI, Ibogaine for Access for Benefit Sharing (ABS) is our mission to help new natural medicine products and phytopharmaceutical businesses globally to generate tangible growth as a private sector partnership in the US and indigenous communities partnerships globally. At the same time, our heart lies in giving back to society.

We empower the next generation by equipping underprivileged OUD/SUD patients with Harm reduction education with our analytical services for Know Your Drugs app and campaigns.